Consensus Monopar Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-15 EDT			5-day change	1st Jan Change
0.5981 ^USD	-8.13%		-20.25%	+75.81%

05-09	Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct	MT

5cba9327d.KOJo-_8SfcalgxxtmcL00nmZAWLx6l_TJ4NcUEuzbwE.TacSkoV5EvLT0WwEtKDFkSjQcgXcjjCySsIeHjieJktbjzmPq3YHgv2zew~3dd2eb2302b2135cee91c9e8757dcc39

JonesTrading Upgrades Monopar Therapeutics to Buy From Hold, Price Target is $2	04-11	MT
JonesTrading Downgrades Monopar Therapeutics to Hold From Buy	23-08-10	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $2 From $6, Keeps Buy Rating	23-05-15	MT
Maxim Group Downgrades Monopar Therapeutics to Hold From Buy	23-03-29	MT
Roth MKM Adjusts Price Target on Monopar Therapeutics to $3 From $18, Maintains Buy Rating	23-03-28	MT
EF Hutton Adjusts Price Target on Monopar Therapeutics to $17 From $24, Maintains Buy Rating	23-03-28	MT
Roth Capital Reinstates Monopar Therapeutics at Buy With $18 Price Target	22-12-09	MT
Wall Street Set to Open Lower as Mortgage Rates Climb to 16-Year High	22-10-05	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $6 From $9, Maintains Buy Rating	22-08-16	MT
HC Wainwright Starts Monopar Therapeutics at Buy With $9 Price Target	21-11-01	MT
MONOPAR THERAPEUTICS : Roth Capital Starts Monopar Therapeutics at Buy With $49 Price Target	21-01-28	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.5981 USD

Average target price

2.08 USD

Spread / Average Target

+247.77%

High Price Target

2.16 USD

Spread / Highest target

+261.14%

Low Price Target

2 USD

Spread / Lowest Target

+234.39%

JonesTrading Institutional Services
HC Wainwright
Maxim
EF Hutton
Roth MKM
Roth Capital Partners